Christopher C Dvorak

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation
    C C Dvorak
    Division of Pediatric Hematology, Oncology, and Bone Marrow Transplantation, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    Bone Marrow Transplant 36:621-9. 2005
  2. ncbi request reprint Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite-based chemotherapy
    Christopher C Dvorak
    Division of Pediatric Hematology, Oncology, and Bone Marrow Transplantation, Stanford University School of Medicine, Palo Alto, California 94304, USA
    Pediatr Blood Cancer 48:582-5. 2007
  3. ncbi request reprint Liposomal amphotericin B associated with severe hyperphosphatemia
    Scott M Sutherland
    Division of Pediatric Nephrology, Department of Pediatrics, Lucile Packard Children s Hospital, Stanford University, Palo Alto, CA, USA
    Pediatr Infect Dis J 27:77-9. 2008
  4. doi request reprint Safety of hematopoietic stem cell transplantation in children less than three years of age
    Christopher C Dvorak
    Division of Pediatric Stem Cell Transplantation, Stanford University School of Medicine, Stanford, CA, USA
    Pediatr Hematol Oncol 25:705-22. 2008
  5. doi request reprint Megadose CD34(+) cell grafts improve recovery of T cell engraftment but not B cell immunity in patients with severe combined immunodeficiency disease undergoing haplocompatible nonmyeloablative transplantation
    Christopher C Dvorak
    Division of Pediatric Blood and Marrow Transplant, University of California San Francisco Children s Hospital, San Francisco, CA, USA
    Biol Blood Marrow Transplant 14:1125-33. 2008
  6. ncbi request reprint Optimizing care for GI disorders in children after hematopoietic stem cell transplantation
    William Berquist
    Gastrointest Endosc 64:386-8. 2006
  7. pmc Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia
    Christopher C Dvorak
    Division of Pediatric Blood and Marrow Transplantation, University of California, San Francisco, California 94143 1278, USA
    Biol Blood Marrow Transplant 14:824-30. 2008

Detail Information

Publications7

  1. ncbi request reprint Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation
    C C Dvorak
    Division of Pediatric Hematology, Oncology, and Bone Marrow Transplantation, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    Bone Marrow Transplant 36:621-9. 2005
    ..Thus, IFI is a significant cause of nonrelapse mortality in children undergoing allogeneic HCT and more effective strategies are needed to prevent and treat IFI...
  2. ncbi request reprint Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite-based chemotherapy
    Christopher C Dvorak
    Division of Pediatric Hematology, Oncology, and Bone Marrow Transplantation, Stanford University School of Medicine, Palo Alto, California 94304, USA
    Pediatr Blood Cancer 48:582-5. 2007
    ..These cases demonstrate that there is a role for ATRA plus differentiating chemotherapy other than arsenic trioxide in the treatment of relapsed APML...
  3. ncbi request reprint Liposomal amphotericin B associated with severe hyperphosphatemia
    Scott M Sutherland
    Division of Pediatric Nephrology, Department of Pediatrics, Lucile Packard Children s Hospital, Stanford University, Palo Alto, CA, USA
    Pediatr Infect Dis J 27:77-9. 2008
    ..Resolution of the hyperphosphatemia occurred after transition to amphotericin B lipid complex. This phenomenon may occur more commonly in patients with mild to moderate renal insufficiency...
  4. doi request reprint Safety of hematopoietic stem cell transplantation in children less than three years of age
    Christopher C Dvorak
    Division of Pediatric Stem Cell Transplantation, Stanford University School of Medicine, Stanford, CA, USA
    Pediatr Hematol Oncol 25:705-22. 2008
    ..Cyclophosphamide-related perineal dermatitis is a unique complication in very young children. Finally, the incidence of acute and chronic GvHD in this population is low...
  5. doi request reprint Megadose CD34(+) cell grafts improve recovery of T cell engraftment but not B cell immunity in patients with severe combined immunodeficiency disease undergoing haplocompatible nonmyeloablative transplantation
    Christopher C Dvorak
    Division of Pediatric Blood and Marrow Transplant, University of California San Francisco Children s Hospital, San Francisco, CA, USA
    Biol Blood Marrow Transplant 14:1125-33. 2008
    ....
  6. ncbi request reprint Optimizing care for GI disorders in children after hematopoietic stem cell transplantation
    William Berquist
    Gastrointest Endosc 64:386-8. 2006
  7. pmc Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia
    Christopher C Dvorak
    Division of Pediatric Blood and Marrow Transplantation, University of California, San Francisco, California 94143 1278, USA
    Biol Blood Marrow Transplant 14:824-30. 2008
    ..Autologous HSCT is associated with a low incidence of TRM, whereas allogeneic HSCT is associated with a low incidence of relapse, suggesting a strong GVL effect against residual APL...